{
    "clinical_study": {
        "@rank": "127833", 
        "arm_group": [
            {
                "arm_group_label": "Extended-Release Carvedilol Sulfate", 
                "arm_group_type": "Experimental", 
                "description": "18-72mg/d,po"
            }, 
            {
                "arm_group_label": "Sustained-release Metoprolol Succinate", 
                "arm_group_type": "Active Comparator", 
                "description": "11.875-190mg/d,po"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of present study is to evaluate the efficacy and safety of Extended-Release\n      Carvedilol Sulfate versus Sustained-release Metoprolol Succinate in Patients With Mild or\n      Moderate Chronic Heart Failure."
        }, 
        "brief_title": "A Phase \u2162 Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure", 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males or Females\n\n          -  Aged from 18 to 75 years\n\n          -  New York Heart Association(NYHA) classification \u2161-\u2162\n\n          -  At screening, subject has an LVEF<0.45\n\n          -  Have received optimal therapy with an Angiotensin converting enzyme inhibitors or\n             angiotensin receptor blocker  for 4 weeks before enrollment\n\n          -  Subjects with symptoms of Stable heart failure do not need intravenous injection\n             diuretics,cardiac inotropes or vasodilators\n\n          -  Willing to provide written informed consent\n\n        Exclusion Criteria:\n\n          -  Current treatment on any Class I or III antiarrhythmic, except amiodarone or\n             beta-blockers\n\n          -  Current treatment on calcium antagonists except for long-acting dihydropyridine\n             agents\n\n          -  Have a history of acute coronary syndrome,cerebral apoplexy or transient ischemic\n             attack with 3 months\n\n          -  Have a history of  cardio-vascular surgery or other vessel operations with 3 months\n\n          -  Have a history of sustained ventricular tachycardia or ventricular fibrillation with\n             3 months\n\n          -  Have a plan to receive coronary revascularization or heart transplantation\n\n          -  Uncontrolled ventricular arrhythmias (not controlled with antiarrhythmic therapy or\n             an implantable defibrillator)\n\n          -  Subjects with uncorrected primary obstructive or severe regurgitative valvular\n             disease\uff0cnondilated (restrictive) or hypertrophic cardiomyopathy\n\n          -  Sitting systolic blood pressure\u226490mmHg (based on an average of 3 readings)\n\n          -  Current decompensated heart failure\n\n          -  Second or third degree heart block\uff0cor sick sinus syndrome\uff0ca pacemaker is not placed\n\n          -  Contraindication to vasodilators\n\n          -  Have a history of cardiac resynchronization therapy or\n\n          -  Have received cardioverter defibrillator or  pacemaker  with 1 month\n\n          -  Resting heart rate<50 beats per minute(based on the average of 3 readings)\n\n          -  Elevated liver enzymes (alanine aminotransferase or aspartate aminotransferase levels\n             greater than 3 times upper limit of normal)\n\n          -  Serum creatinine levels greater than 2 times upper limit of normal\n\n          -  Current clinical evidence of obstructive pulmonary disease (e.g., asthma or\n             bronchitis) requiring inhaled or oral bronchodilator or steroid therapy\n\n          -  History of drug sensitivity or allergic reaction to alpha or beta-blockers\n\n          -  Contraindication or intolerance to beta-blockers\n\n          -  Pregnant or lactating women and women planning to become pregnant\n\n          -  Has any systemic disease, including cancer, with reduced life expectancy (<12 months)\n\n          -  Use of an investigational drug within 30 days of enrollment\n\n          -  Participation in an investigational device trial within 30 days of enrollment\n\n          -  Known drug or alcohol abuse 1 year prior to enrollment\n\n          -  Has a history of psychological illness/condition that interferes with ability to\n             understand or complete requirements of the study\n\n          -  In the opinion of the investigator the subject is known to be noncompliant with\n             prescribed medication regimen"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "316", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02012075", 
            "org_study_id": "KWDLHF2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Extended-Release Carvedilol Sulfate", 
                "intervention_name": "Extended-Release Carvedilol Sulfate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sustained-release Metoprolol Succinate", 
                "intervention_name": "Sustained-release Metoprolol Succinate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Metoprolol", 
                "Carvedilol", 
                "Metoprolol succinate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 10, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Lanzhou", 
                        "country": "China", 
                        "state": "Gansu"
                    }, 
                    "name": "Gansu Provincial Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei", 
                        "zip": "430030"
                    }, 
                    "name": "Tongji Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changsha", 
                        "country": "China", 
                        "state": "Hunan"
                    }, 
                    "name": "The Second Xiangya Hospital of Central South University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changsha", 
                        "country": "China", 
                        "state": "Hunan"
                    }, 
                    "name": "The Third Xiangya Hospital of Central South University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yangzhou", 
                        "country": "China", 
                        "state": "Jiangsu", 
                        "zip": "225001"
                    }, 
                    "name": "Northern Jiangsu People's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "110004"
                    }, 
                    "name": "Shengjing Hospital of China Medical University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang"
                    }, 
                    "name": "The First Affiliated Hospital of College of Medicine, Zhejiang University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taizhou", 
                        "country": "China", 
                        "state": "Zhejiang"
                    }, 
                    "name": "Taizhou Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "chshma@vip.sina.com", 
                    "last_name": "Changsheng Ma, Professor", 
                    "phone": "86-010-64456078"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100029"
                    }, 
                    "name": "Beijing ANZHEN Hospital"
                }, 
                "investigator": {
                    "last_name": "Changsheng Ma, Professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100029"
                    }, 
                    "name": "China-Japan Friendship Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Beijing Tongren hospital affiliated to Capital Medical University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "zip": "100053"
                    }, 
                    "name": "Xuan Wu Hospital affiliated to Capital Medical University"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy and Safety Comparison of Extended-Release Carvedilol Sulfate and Sustained-release Metoprolol Succinate in Patients With Heart Failure", 
        "overall_contact": {
            "email": "chshma@vip.sina.com", 
            "last_name": "Changsheng Ma, Professor", 
            "phone": "86-010-64456078"
        }, 
        "overall_official": {
            "affiliation": "Beijing Anzhen Hospital", 
            "last_name": "Changsheng Ma, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change From Baseline in left ventricular ejection fraction(LVEF) by ultrasound cardiogram", 
            "safety_issue": "No", 
            "time_frame": "Baseline and Week 36"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02012075"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change From Baseline in Left Ventricular End Systolic Volume Index", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Week 36"
            }, 
            {
                "measure": "Change From Baseline in Left Ventricular End Diastolic Volume Index", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Week 36"
            }, 
            {
                "measure": "Incidence of Hospitalizations From Exacerbation of Heart Failure", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Week 36"
            }, 
            {
                "measure": "Incidence of Hospitalizations From  All Causes", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and Week 36"
            }, 
            {
                "measure": "Incidence of Deaths From All Causes", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline and Week 36"
            }, 
            {
                "measure": "Change From Baseline in New York Heart Association\uff08NYHA\uff09classification", 
                "safety_issue": "No", 
                "time_frame": "Baseline and Week 36"
            }
        ], 
        "source": "Jiangsu HengRui Medicine Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Jiangsu HengRui Medicine Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}